Innovation Pharmaceuticals Inc (IPIX)

[Drano]

brucethepotter, it looks like your father-in-law is comparing apples to oranges. That other stock has already gone from about 8-10 earlier this year, to around 28 now. Some analyst or other has a target of 32 on it.

Being at an earlier stage in clinical trials, CTIX has not made that kind of move yet, and as we have discussed ad nauseam, it's still on the pink sheets. That other company is actually planning to market the drug themselves, and says they want to acquire some other (unnamed and perhaps as yet unidentified by them) company. CTIX has made it clear that they do NOT want to be marketing the drug but will seek partnership or licensing. CTIX is in early stages, and the other company is in a much later stage of development.

The big money is made by getting in a company early, before it has the huge move upward. If the other company is at around 28, and the analyst's price target is 32, that's not much upside. CTIX could double or triple on good news.

And, CTIX is not only in the business of developing antibiotics, but has two other distinctly different diseases it is addressing. In the unlikely event Brilacidin fails, the company is not dependent solely on it.

So I would say, CTIX is actually the less risky investment here. Can you get him to read Karin's article?